Author:
Motamed Nima,Zamani Farhad,Maadi Mansooreh,Ajdarkosh Hossein,Roozafzai Farzin,Keyvani Hossein,Poustchi Hossein,Shakeri Ramin,Ashrafi G. Hossein,Perumal Dhayaneethie,Rabiee Behnam,Moradi-Lakeh Maziar,Khoonsari Mahmoodreza,Kheyri Zahedin,Sohrabi Masoud Reza,Doustmohammadian Azam,Amirkalali Bahareh,Safarnezhad Tameshkel Fahimeh,Gholizadeh Esmaeel,Hosseini Seyed Hamzeh,Karbalaie Niya Mohammad Hadi
Abstract
BackgroundIran is facing an epidemiological transition with the increasing burden of non-communicable diseases, such as obesity-related disorders and cardiovascular diseases (CVDs). We conducted a population-based prospective study to assess the prevalence and incidence rates of CVDs and obesity-related metabolic disorders and to evaluate the predictive ability of various CVD risk assessment tools in an Iranian population.MethodWe enrolled 5,799 participants in Amol, a city in northern Iran, in 2009–2010 and carried out the first repeated measurement (RM) after seven years (2016–2017). For all participants, demographic, anthropometric, laboratory, hepatobiliary imaging, and electrocardiography data have been collected in the enrollment and the RM. After enrollment, all participants have been and will be followed up annually for 20 years, both actively and passively.ResultsWe adopted a multidisciplinary approach to overcome barriers to participation and achieved a 7-year follow-up success rate of 93.0% with an active follow-up of 5,394 participants aged 18–90 years. In the RM, about 64.0% of men and 81.2% of women were obese or overweight. In 2017, about 16.2% and 5.2% of men had moderate or severe non-alcoholic fatty liver disease, while women had a significantly higher prevalence of metabolic syndrome (35.9%), and type 2 diabetes mellitus (20.9%) than men. Of 160 deceased participants, 69 cases (43.1%) died due to CVDs over seven years.ConclusionThe most prevalent obesity-related chronic disease in the study was metabolic syndrome. Across the enrollment and RM phases, women exhibited a higher prevalence of obesity-related metabolic disorders. Focusing on obesity-related metabolic disorders in a population not represented previously and a multidisciplinary approach for enrolling and following up were the strengths of this study. The study outcomes offer an evidence base for future research and inform policies regarding non-communicable diseases in northern Iran.
Reference59 articles.
1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019;Lancet,2020
2. The PERSIAN cohort: providing the evidence needed for healthcare reform;Eghtesad;Arch Iran Med,2017
3. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019;Farzadfar;Lancet,2022
4. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献